Xerese (Valeant Pharmaceuticals North America LLC)


Welcome to the PulseAid listing for the Xerese drug offered from Valeant Pharmaceuticals North America LLC. This DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Valeant Pharmaceuticals North America LLC
NON-PROPRIETARY NAME: Acyclovir and Hydrocortisone
SUBSTANCE NAME: ACYCLOVIR; HYDROCORTISONE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
ROUTE: TOPICAL
DOSAGE FORM: CREAM
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-07-31
END MARKETING DATE: 0000-00-00


Xerese HUMAN PRESCRIPTION DRUG Details:

Item DescriptionXerese from Valeant Pharmaceuticals North America LLC
LABELER NAME: Valeant Pharmaceuticals North America LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 50; 10(mg/g; mg/g)
START MARKETING DATE: 2009-07-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0187-5104_55989c60-a53f-45fe-a543-894782c85f91
PRODUCT NDC: 0187-5104
APPLICATION NUMBER: NDA022436

Other ACYCLOVIR; HYDROCORTISONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Valeant Pharmaceuticals North America LLCXerese